[Federal Register Volume 62, Number 244 (Friday, December 19, 1997)]
[Notices]
[Page 66666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33115]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 25, 1997, Cambridge 
Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810, made 
application by renewal, which was received for processing on November 
4, 1997, to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Methaqualone (2565)...........................................        I 
Dimethyltryptamine (7435).....................................        I 
Amphetamine (1100)............................................       II 
Methamphetamine (1105)........................................       II 
Pentobarbital (2270)..........................................       II 
Secobarbital (2315)...........................................       II 
Phencyclidine (7471)..........................................       II 
Phenylacetone (8501)..........................................       II 
Cocaine (9041)................................................       II 
Codeine (9050)................................................       II 
Oxycodone (9143)..............................................       II 
Hydromorphone (9150)..........................................       II 
Benzoylecgonine (9180)........................................       II 
Methadone (9250)..............................................       II 
Dextropropoxyphene, bulk (non-dosage forms) (9273)............       II 
Morhone (9300)................................................       II 
Fentanyl (9801)...............................................       II 
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the above listed 
controlled substances for isotope labeled standards for drug analysis.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than February 17, 1998.

    Dated: November 28, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-33115 Filed 12-18-97; 8:45 am]
BILLING CODE 4410-09-M